Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02114164 · ClinicalTrials.gov registry record · NA

Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies

A NA study of Prostate Cancer and Pneumoperitoneum, sponsored by OhioHealth.

Completed
Registry status
NA
Development phase
109
Enrollment target
1
Study location

NCT02114164: Completed NA study of Prostate Cancer and Pneumoperitoneum, sponsored by OhioHealth.

NCT02114164 is a NA study of Prostate Cancer and Pneumoperitoneum that has completed, run by OhioHealth. The registered enrollment target is 109 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02114164, a NA study of Prostate Cancer and Pneumoperitoneum, has completed, sponsored by OhioHealth.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

The AirSeal® System will allow for lower carbon dioxide (CO2) absorption rates than the standard Endopath System.

Primary Outcome

Pneumoperitoneal pressure is the pressure exerted by air or gas in the abdominal (peritoneal) cavity. As the amount of air/gas increases, the pressure (mmHg) increases. The highest pressure that occurred during the procedure was compared between groups.

Interventions

  • DEVICE AirSeal System
  • DEVICE Standard Endopath

Study Locations (1)

Ohio

  • Dublin Methodist Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2016-08
Est. Completion 2019-07-15
Phase NA
OhioHealth

20 total trials

What the finished NCT02114164 record still lists

NCT02114164 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which AirSeal System is the first listed.

NCT02114164 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02114164 about?

NCT02114164 is a clinical study titled "Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies". The AirSeal® System will allow for lower carbon dioxide (CO2) absorption rates than the standard Endopath System.

What is the current status of trial NCT02114164?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2016-08. Estimated completion is 2019-07-15.

What conditions does trial NCT02114164 study?

This clinical trial studies the following conditions: Prostate Cancer, Pneumoperitoneum.

What interventions are being tested in trial NCT02114164?

The interventions under investigation include: AirSeal System (DEVICE), Standard Endopath (DEVICE).

Who is sponsoring clinical trial NCT02114164?

This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02114164 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02114164's enrollment target sits among peer trials

109 322nd of 735 higher than 414 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02114164, the US trial registry maintained by the National Library of Medicine. NCT02114164 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.